A series of studies indicated that iron distribution that partly derives from transferrin-bound iron in the peripheral nervous system in the brain may act in processes such as myelination and brain development. However, the relationship between schizophrenia, its psychotic symptoms, and the transferrin (TF) gene has not been systematically explored. Our study aimed to investigate how a particular polymorphism of the transferrin gene, rs3811655, affects the superoxide dismutase (SOD), malondialdehyde (MDA), psychotic symptoms, cognition, or the mediation model between antioxidant enzymes and cognition via symptoms. A total of 564 patients with chronic schizophrenia and 468 healthy control subjects were recruited. The psychotic symptoms and cognition were assessed by the Positive and Negative Syndrome Scale (PANSS) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), respectively. Furthermore, the serum SOD, MDA activity, and transferrin gene polymorphism were measured in patients. Our results demonstrated that patients with the G allele possessed more severe negative symptoms, worse cognitive performance with respect to attention, and higher serum Mn-SOD activity. Additionally, the rs3811655 polymorphism may act as a moderator in the association between Cu/Zn-SOD activity and cognition, as well as psychotic symptoms in patients suffering from schizophrenia. According to this study, the single nucleotide polymorphism (SNP) rs3811655 polymorphism may fail to contribute to the susceptibility of schizophrenia in an individual but is involved in the iron-induced oxidative stress disturbance and cognitive impairment in schizophrenia. This deepens our understanding of the critical role of iron-induced oxidative stress that might underlie the pathophysiology of schizophrenia.
24 February 2023 in Journal of Neuroscience Research
A large amount of recent literature has focused on impaired iron homeostasis in the pathophysiology of schizophrenia. Specifically, microarray analysis has illustrated associations between the transferrin locus and schizophrenia. To elaborate on the effects of transferrin on schizophrenia and its psychiatric phenotypes, our study aimed to investigate whether transferrin gene polymorphism was correlated with cognitive deficits and clinical symptoms in schizophrenia. We recruited 564 patients with chronic schizophrenia and 422 healthy controls (HCs) in a Han Chinese population, collected phenotypic data, and genotyped the rs3811655 polymorphism of the transferrin gene. Our results showed that the rs3811655 polymorphism was related to cognitive performance in both patients and HCs, as well as negative symptoms in patients (all p < 0.05), and patients carrying at least one G-allele showed worsened cognition/severe negative symptoms (all p < 0.05). Further analyses also found that the rs3811655 polymorphism in combination with cognition may exert small but significant contributions to the negative (β = −0.10, t = −2.48, p < 0.05) or total psychiatric symptoms (β = −0.08, t = −1.92, p < 0.05) in patients. Our findings indicated that the rs3811655 polymorphism may be implicated in the cognitive deficits of schizophrenia and HCs as well as psychiatric symptoms in patients, which suggested the possible iron regulatory mechanism in the pathology of schizophrenia.
Background: Sleep loss has sometimes catastrophic effects on risky decision-making. However, it is unknown to what extent such deficits are exacerbated with increasing duration of sleep deprivation (SD) and whether sustained vigilant attention mediates this sleep deprivation-induced deficit.Methods: The present study aimed to investigate the effect of 36 hours of SD on 37 male college students’ arousal, emotion, vigilant attention, and risky decision-making, using the Psychomotor Vigilance Test, the Game of Dice Task, and scales assessing fatigue, sleep, and emotions. Results: Compared to baseline, SD significantly increased sleepiness, fatigue, and negative emotions, decreased positive emotions and vigilant attention, and led to a shift toward risky decision-making, and these effects often appeared 15 or 20 hours after SD. Interestingly, participants’ ability to employ positive feedback was maintained, whereas their performance to utilize negative feedback was impaired even after 8 hours of sleep deprivation. Meanwhile, vigilant attention acted as a mediator between SD and risky decision-making (z = -1.97, 95% [-6.00, -0.30]).Discussion: These results suggest that sleep-deprived individuals are unable to use negative feedback to optimize their judgments, which may account for their poor decision-making under risk.
15 November 2025 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics